Developing and commercializing cancer cure is one of my long-term, multidecadal commitments in advancing biotech.
Because cancer is linked to cell growth, cell division, telomere, and telomerase, I believe that cancer cure research is also linked to anti-aging and deaging biotech, or human longevity biotech.
So, I pursue cancer cure research in tandem with human longevity biotech research.
A quick advertisement before I continue on this topic. I’m seeking accredited investors in my startup with an SEC Regulation D Rule 506(c) offering. If you’re interested in investing in my startup as an accredited investor, voice call me or message me on Instagram to discuss investing in Robocentric. Visit Robocentric.com/Investors for more info on investing in Robocentric; visit Robocentric.com/About to learn more about Robocentric. Now, back to the main content.
Searching online “how to induce cancer in lab rat” gives a number of different ways to induce cancer in a lab rat—such as xenografting carcinogenesis, syngeneic carcinogenesis, radiation carcinogenesis, chemical carcinogenesis, and genetic-mutation carcinogenesis.
I want the cheapest, fastest, surest, and most biotechnologically advanced way to induce cancer in lab rats because I see that as conducive to developing the cancer-cure medical biotech. My reasoning is that in order to be able to develop the cancer cure or cures that can cure all forms and types of cancer, science must first find out all the precise causes of all the different forms and types of cancers, and biotech must be able to cause or induce all the different forms and types of cancers in laboratory animals; if you don’t know all the precise causes, you cannot eliminate all the effects; as such, in order to eliminate all the effects of having cancer, one must first find out all the causes of having cancer at the biological-body subsystem, organic, tissular, cellular, subcellular, molecular, atomic, and subatomic levels.
I’ll keep on doing my research for developing and commercializing a set of biotechnologies for causing or inducing cancers in rats and other laboratory animals, that will contribute to realizing the cure or cures for all the different forms and types of cancers, and realizing the human longevity biotech.
One ultimate aim I pursue in advancing biotech is developing and commercializing the human longevity biotech, or the human anti-aging and deaging biotech, that will enable humans to live 150 years or more with young, healthy, and beautiful human bodies, so I want every research I do in advancing biotech to contribute to advancing and enabling the human longevity biotech in some way; so, I’ll take the direction of even developing and commercializing a lab-rat cancer inducer biotech somehow contributing to advancing and enabling the human longevity biotech that I envision and aim to develop and commercialize.
Searching online “how to detect cancer in lab rat” gives using MRI (Magnetic Resonance Imaging) and biopsy for detecting cancer in lab rats, just like in humans.
I’ll keep working on developing and commercializing one or more biotechnologies for quickly, easily, and cheaply detecting cancer in lab animals and humans, for developing cancer cure and human longevity biotech.
You can invest in my startup company with as little as US$100, for supporting advancing AI, robotics, biotech, and nuclear-fusion powered outer space tech. Visit Robocentric.com/Investors to invest in my startup.
My books on advancing AI, robotics, biotech, and nuclear-fusion powered outer space tech are available at Robocentric.com/Checkout, Amazon, Apple Books, Spotify, Google Play Store, and other online audiobook retailers.
I am Allen Young; I’m an Asian-American man who focuses on advancing AI, robotics, human longevity biotech, and nuclear-fusion powered outer space tech.